NCT03259126 (EXTRA-RAD) is a NA clinical trial of SCUT in Radiation, sponsored by Ospedale Sandro Pertini, Roma.

Who is sponsoring NCT03259126?

NCT03259126 is sponsored by Ospedale Sandro Pertini, Roma.

What drugs are being tested in NCT03259126?

Interventions in NCT03259126: SCUT.

What condition does NCT03259126 study?

NCT03259126 studies Radiation, X-rays; Effects, Coronary Disease.

Is NCT03259126 still recruiting?

NCT03259126 is currently completed. Last updated 20 August 2018.

Last reviewed 2018-08-20 · How we verify

NCT03259126: EXTRA-RAD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EXTended pRotective Curtain Under Table to Reduce Operator RAdiation Dose in Percutaneous Coronary Procedures

Completed NA Last updated 20 August 2018

What this trial tests

NA trial testing SCUT in Radiation in 157 participants. Completed in 13 August 2018.

Timeline

7 August 2017

Primary endpoint
13 August 2018

13 August 2018

Quick facts

Lead sponsor	Ospedale Sandro Pertini, Roma
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	157
Start date	7 August 2017
Primary completion	13 August 2018
Estimated completion	13 August 2018
Sites	1 location across Italy

Drugs / interventions tested

SCUT

Conditions studied

Radiation — all drugs for Radiation →
X-rays; Effects — all drugs for X-rays; Effects →
Coronary Disease — all drugs for Coronary Disease →

Sponsor

Ospedale Sandro Pertini, Roma

Who can join

18 and older, any sex, with Radiation or X-rays; Effects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radiation dose to interventional cardiologists performing transradial percutaneous coronary procedures is higher compared to those performing transfemoral exams. The radiation dose seems particularly high at pelvic level. We prepared an home-made protective extension of the leaded curtain under table that should reduce the operator exposure during interventional coronary procedures. The aim of the study is to evaluate the procedural efficacy of the protective extension on the operator radiation dose at pelvic level

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Extended Protective Shield Under Table to Reduce Operator Radiation Dose in Percutaneous Coronary Procedures.
Sciahbasi A, Sarandrea A, Rigattieri S, Patrizi R, et al · · 2019 · cited 7× · PMID 30732471 · DOI 10.1161/circinterventions.118.007586

Verify or expand the search:

Other recruiting trials for Radiation

Currently open trials in the same condition.

NCT06295783 — Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect · recruiting
NCT06253338 — Optimization of Radiation Protection Through Genomic Analyses · NA · recruiting
NCT06514118 — Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer · recruiting
NCT06230549 — Adaptive Radiotherapy in Patients With Gynecological Tumors · NA · recruiting
NCT06214611 — Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors · NA · recruiting

Other Ospedale Sandro Pertini, Roma trials

Trials by the same sponsor.

NCT05340998 — Radial accEss Crossover for PErcutaneous Coronary Procedures And ouTcome: the REPEAT Study · completed
NCT05227014 — Enhanced Recovery and Patient Blood Management in Colorectal Surgery · unknown
NCT04753775 — RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03259126 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ospedale Sandro Pertini, Roma
Last refreshed: 20 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03259126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing